The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 09, 2019
Filed:
Apr. 11, 2018
Applicant:
Zealand Pharma A/s, Glostrup, DK;
Inventors:
Rasmus Just, Copenhagen, DK;
Kirsten Lindegaard Bovbjerg, Hørsholm, DK;
Ditte Riber, Brønshøj, DK;
Wayne Shaun Russell, Kävlinge, SE;
Assignee:
Zealand Pharma A/S, Glostrup, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 14/00 (2006.01); C07K 14/605 (2006.01); A61K 38/26 (2006.01); A61K 35/22 (2015.01); A61K 35/48 (2015.01); A61K 35/54 (2015.01); A61K 35/64 (2015.01); A61K 45/06 (2006.01); A61K 35/63 (2015.01);
U.S. Cl.
CPC ...
C07K 14/605 (2013.01); A61K 35/22 (2013.01); A61K 35/48 (2013.01); A61K 35/54 (2013.01); A61K 35/63 (2015.01); A61K 35/64 (2013.01); A61K 38/26 (2013.01); A61K 45/06 (2013.01);
Abstract
GLP-2 analogs are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogs are particularly useful for the prophylaxis treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.
Just, Rasmus. (2019). Glucagon-like-peptide-2 (glp-2) analogues (U.S. Patent No. 10253080). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10253080
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile